Daniel Layish

644 total citations
10 papers, 237 citations indexed

About

Daniel Layish is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Daniel Layish has authored 10 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Daniel Layish's work include Cystic Fibrosis Research Advances (4 papers), Ultrasound in Clinical Applications (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). Daniel Layish is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Ultrasound in Clinical Applications (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). Daniel Layish collaborates with scholars based in United States, United Kingdom and Italy. Daniel Layish's co-authors include Victor F. Tapson, Michael H. O’Shea, Robert D. Davis, David N. Howell, Joseph A. Govert, Maher A. Baz, H. Dirk Sostman, D M DeLong, Pamela K. Woodard and Philip C. Goodman and has published in prestigious journals such as PLoS ONE, CHEST Journal and Journal of the American Society of Nephrology.

In The Last Decade

Daniel Layish

10 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Layish United States 7 103 87 76 61 46 10 237
E. Lavenne Belgium 7 141 1.4× 31 0.4× 38 0.5× 55 0.9× 79 1.7× 13 251
Parul Rathor China 6 85 0.8× 75 0.9× 35 0.5× 175 2.9× 42 0.9× 7 270
José Luis Alonso-Martínez Spain 7 104 1.0× 47 0.5× 40 0.5× 220 3.6× 27 0.6× 14 316
Paul Egermayer New Zealand 8 213 2.1× 56 0.6× 165 2.2× 159 2.6× 49 1.1× 17 371
António Leitão Marques Portugal 9 81 0.8× 55 0.6× 26 0.3× 198 3.2× 10 0.2× 36 297
Yahya Kemal İçen Türkiye 10 32 0.3× 63 0.7× 33 0.4× 212 3.5× 22 0.5× 51 334
Raquel López-Reyes Spain 8 93 0.9× 28 0.3× 80 1.1× 81 1.3× 23 0.5× 16 224
F. Vécina France 7 39 0.4× 51 0.6× 68 0.9× 49 0.8× 9 0.2× 16 233
B. Kirke Bieneman United States 7 185 1.8× 73 0.8× 42 0.6× 87 1.4× 28 0.6× 8 336
Beata Zaborska Poland 12 80 0.8× 55 0.6× 68 0.9× 439 7.2× 16 0.3× 52 519

Countries citing papers authored by Daniel Layish

Since Specialization
Citations

This map shows the geographic impact of Daniel Layish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Layish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Layish more than expected).

Fields of papers citing papers by Daniel Layish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Layish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Layish. The network helps show where Daniel Layish may publish in the future.

Co-authorship network of co-authors of Daniel Layish

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Layish. A scholar is included among the top collaborators of Daniel Layish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Layish. Daniel Layish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Devereux, Graham, Stephen Bourke, Cori Daines, et al.. (2020). Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial. PLoS ONE. 15(12). e0242945–e0242945. 9 indexed citations
2.
Devereux, G., S. Bourke, Cori Daines, et al.. (2019). WS12-6 Evaluating appropriate PROMs in CARE-CF-1 trial: Lynovex® (cysteamine) an oral adjunct to SOC interventions in cystic fibrosis infectious exacebations. Journal of Cystic Fibrosis. 18. S23–S24. 1 indexed citations
3.
Jain, Manish K., Joseph M. Pilewski, Patrick A. Flume, et al.. (2019). WS06-2 Initial results evaluating the add-on effect of the novel CFTR corrector PTI-801 in cystic fibrosis subjects. Journal of Cystic Fibrosis. 18. S10–S11. 3 indexed citations
4.
Flume, Patrick A., Gregory S. Sawicki, T. Pressler, et al.. (2018). WS01.2 Phase 2 initial results evaluating PTI-428, a novel CFTR amplifier, in patients with cystic fibrosis. Journal of Cystic Fibrosis. 17. S1–S2. 8 indexed citations
5.
Palmer, Scott M., Daniel Layish, Peter S. Kussin, et al.. (1998). Lung Transplantation for Williams-Campbell Syndrome. CHEST Journal. 113(2). 534–537. 12 indexed citations
6.
Layish, Daniel & Victor F. Tapson. (1997). New imaging techniques for the diagnosis of pulmonary embolism. Current Opinion in Pulmonary Medicine. 3(4). 280–285. 4 indexed citations
7.
Layish, Daniel & Victor F. Tapson. (1997). Pharmacologic Hemodynamic Support in Massive Pulmonary Embolism. CHEST Journal. 111(1). 218–224. 66 indexed citations
8.
Sostman, H. Dirk, Daniel Layish, Victor F. Tapson, et al.. (1996). Prospective comparison of helical CT and MR imaging in clinically suspected acute pulmonary embolism. Journal of Magnetic Resonance Imaging. 6(2). 275–281. 61 indexed citations
9.
Baz, Maher A., Daniel Layish, Joseph A. Govert, et al.. (1996). Diagnostic Yield of Bronchoscopies After Isolated Lung Transplantation. CHEST Journal. 110(1). 84–88. 50 indexed citations
10.
O’Shea, Michael H. & Daniel Layish. (1992). Growth hormone and the kidney. Journal of the American Society of Nephrology. 3(2). 157–161. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026